HomeNURL • CNSX
add
Neural Therapeutics Inc
Previous close
$0.025
Day range
$0.025 - $0.035
Year range
$0.020 - $0.050
Market cap
2.22M CAD
Avg Volume
35.00K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 247.76K | 148.84% |
Net income | -981.74K | -700.29% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 251.38K | 971.82% |
Total assets | 315.29K | 600.54% |
Total liabilities | 907.75K | 55.92% |
Total equity | -592.45K | — |
Shares outstanding | 88.70M | — |
Price to book | -2.50 | — |
Return on assets | -141.74% | — |
Return on capital | -292.13% | — |
Cash Flow
Net change in cash
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -981.74K | -700.29% |
Cash from operations | -274.57K | -487.57% |
Cash from investing | — | — |
Cash from financing | 5.89K | — |
Net change in cash | -268.68K | -474.97% |
Free cash flow | -314.16K | -13.15% |
About
Founded
2020
Headquarters
Website
